BioCentury

1:10 AM GMT, Apr 11, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Financial News

Amgen up on Roche appeal

Amgen (NASDAQ:AMGN) was up $2.39 to $43.98 after

Read the full 85 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.